-
Loading metrics
EGFR Inhibitor Erlotinib Delays Disease Progression but Does Not Extend Survival in the SOD1 Mouse Model of ALS
- Claire E. Le Pichon,
- Sara L. Dominguez,
- Hilda Solanoy,
- Hai Ngu,
- Nicholas Lewin-Koh,
- Mark Chen,
- Jeffrey Eastham-Anderson,
- Ryan Watts,
- Kimberly Scearce-Levie
x
- Published: April 26, 2013
- https://doi.org/10.1371/journal.pone.0062342